0001415889-23-000726.txt : 20230110 0001415889-23-000726.hdr.sgml : 20230110 20230110162427 ACCESSION NUMBER: 0001415889-23-000726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230106 FILED AS OF DATE: 20230110 DATE AS OF CHANGE: 20230110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ferra Joseph J Jr CENTRAL INDEX KEY: 0001733790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 23521415 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 4 1 form4-01102023_090113.xml X0306 4 2023-01-06 0001783032 Elevation Oncology, Inc. ELEV 0001733790 Ferra Joseph J Jr C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 false true false false INTERIM CEO & CFO Stock Option (Right to Buy) 0.75 2023-01-06 4 A 0 240000 0 A 2033-01-05 Common Stock 240000 240000 D Stock Option (Right to Buy) 0.75 2023-01-06 4 A 0 30000 0 A 2033-01-05 Common Stock 30000 30000 D The stock option vested as to 25% of the total shares on January 6, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The stock option vests as to 1/6 of the total shares monthly, commencing on February 6, 2023, until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Robert Yang, Attorney-in-Fact 2023-01-10